Nantheia™ A1002N5S leverages Pharmaceutical Grade Cannabidiol Isolate and Ananda’s innovative patented Liquid Structure™ Technology.
Delivered in soft gelatin capsules that allow the CBD to be easily solubilized in aqueous intestinal fluids leading to rapid & efficient absorption in the gastrointestinal tract.
Each softgel delivers 50 mg of CBD.
Currently, Nantheia™ A1002N5S is undergoing assessment in three FDA-approved Clinical Trials, addressing PTSD, Social Anxiety Disorder, and Radiculopathic Pain.
To enable placebo controlled clinical studies we have matching placebo for Nantheia™ A1002N5S
